Clinical Trial Update: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial from City of Hope evaluating CMV-specific CD19-CAR T-cells with CMV-MVA Triplex vaccine after stem cell transplantation in various B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma
• Transformed Non-hodgkin Lymphoma

Drugs mentioned

• CMV-MVA Triplex Vaccine (CMV-MVA Triplex Vaccine)
• CMV-Specific CD19-CAR T-cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: B-Cell Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma | Phase 1 | Status: RECRUITING